MastodyniaAxillarySamplingACChemotherapyCo-survivorCAMNeoadjuvantTherapyCachexiaCyclophosphamideWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MultimodalityTherapyMorpheaHER-2MastectomyPathologicResponseLCISGeneMutationBrachytherapyMRIPhysicalactivity mayreduce therisk of breastcancersMegestrolAcetatePrecisionMedicineRADCystAnastrozoleMetastasisAdjuvantTherapyHormoneReplacementTherapyImmunotherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55GeneticCounselingTyrosine-KinaseInhibitorEstrogenStagingCapecitabineAdvocacyLumpectomyER-Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltHerceptinPaclitaxelMethotrexateLymphoscintigraphyPalbociclibOvarianSuppressionGailModelAlopeciaBI-RADSDoseDenseTherapyTamoxifenBilateralProphylacticMastectomyMultifocalTumorsAdenocarcinomaIn-situCarcinoma5-FluorouracilCheckpointInhibitorAyurvedaChemotherapyPARPInhibitorsGuaranteedRenewableInsuranceCMFChemotherapyCalcificationsBRCAGeneProgestinFISHKappaEpsilonPalpationCytostaticGermlineMutationAromataseInhibitorsSelf-examination1 in 8womenBreastCancerRadiotherapyKi-67RateAntibodyTherapyAbsoluteRiskGenomicTestingAntiemeticDoxorubicinEGFRChemopreventionTriple +/-BreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.PagetDiseaseDown-StagingAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLumpRelapseLymphNodeStatusDimplingIntraductalPapillomaER+PI3KinaseInhibitorsRaloxifeneDefinitiveSurgeryCytotoxicFlowCytometryEstradiolBiopsyFibroadenomaECOGScoreOligometastasesAngiogenesisWomen ages40+ shouldhave a clinicalbreast examat least yearlyBevacizumabGeneticPredispositionmTORInhibitorsPhyllodesTumorEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearHormoneReceptorStatusApoptosisAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTumorGradeFamilyHistoryCDK4/6InhibitorsBOCASERMLapatinibDocetaxelBreastTomosynthesisMastodyniaAxillarySamplingACChemotherapyCo-survivorCAMNeoadjuvantTherapyCachexiaCyclophosphamideWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MultimodalityTherapyMorpheaHER-2MastectomyPathologicResponseLCISGeneMutationBrachytherapyMRIPhysicalactivity mayreduce therisk of breastcancersMegestrolAcetatePrecisionMedicineRADCystAnastrozoleMetastasisAdjuvantTherapyHormoneReplacementTherapyImmunotherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55GeneticCounselingTyrosine-KinaseInhibitorEstrogenStagingCapecitabineAdvocacyLumpectomyER-Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltHerceptinPaclitaxelMethotrexateLymphoscintigraphyPalbociclibOvarianSuppressionGailModelAlopeciaBI-RADSDoseDenseTherapyTamoxifenBilateralProphylacticMastectomyMultifocalTumorsAdenocarcinomaIn-situCarcinoma5-FluorouracilCheckpointInhibitorAyurvedaChemotherapyPARPInhibitorsGuaranteedRenewableInsuranceCMFChemotherapyCalcificationsBRCAGeneProgestinFISHKappaEpsilonPalpationCytostaticGermlineMutationAromataseInhibitorsSelf-examination1 in 8womenBreastCancerRadiotherapyKi-67RateAntibodyTherapyAbsoluteRiskGenomicTestingAntiemeticDoxorubicinEGFRChemopreventionTriple +/-BreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.PagetDiseaseDown-StagingAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLumpRelapseLymphNodeStatusDimplingIntraductalPapillomaER+PI3KinaseInhibitorsRaloxifeneDefinitiveSurgeryCytotoxicFlowCytometryEstradiolBiopsyFibroadenomaECOGScoreOligometastasesAngiogenesisWomen ages40+ shouldhave a clinicalbreast examat least yearlyBevacizumabGeneticPredispositionmTORInhibitorsPhyllodesTumorEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearHormoneReceptorStatusApoptosisAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTumorGradeFamilyHistoryCDK4/6InhibitorsBOCASERMLapatinibDocetaxelBreastTomosynthesis

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Mastodynia
  2. Axillary Sampling
  3. AC Chemotherapy
  4. Co-survivor
  5. CAM
  6. Neoadjuvant Therapy
  7. Cachexia
  8. Cyclophosphamide
  9. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  10. Multimodality Therapy
  11. Morphea
  12. HER-2
  13. Mastectomy
  14. Pathologic Response
  15. LCIS
  16. Gene Mutation
  17. Brachytherapy
  18. MRI
  19. Physical activity may reduce the risk of breast cancers
  20. Megestrol Acetate
  21. Precision Medicine
  22. RAD
  23. Cyst
  24. Anastrozole
  25. Metastasis
  26. Adjuvant Therapy
  27. Hormone Replacement Therapy
  28. Immunotherapy
  29. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  30. Genetic Counseling
  31. Tyrosine-Kinase Inhibitor
  32. Estrogen
  33. Staging
  34. Capecitabine
  35. Advocacy
  36. Lumpectomy
  37. ER-
  38. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  39. Herceptin
  40. Paclitaxel
  41. Methotrexate
  42. Lymphoscintigraphy
  43. Palbociclib
  44. Ovarian Suppression
  45. Gail Model
  46. Alopecia
  47. BI-RADS
  48. Dose Dense Therapy
  49. Tamoxifen
  50. Bilateral Prophylactic Mastectomy
  51. Multifocal Tumors
  52. Adenocarcinoma
  53. In-situ Carcinoma
  54. 5-Fluorouracil
  55. Checkpoint Inhibitor
  56. Ayurveda
  57. Chemotherapy
  58. PARP Inhibitors
  59. Guaranteed Renewable Insurance
  60. CMF Chemotherapy
  61. Calcifications
  62. BRCA Gene
  63. Progestin
  64. FISH
  65. Kappa Epsilon
  66. Palpation
  67. Cytostatic
  68. Germline Mutation
  69. Aromatase Inhibitors
  70. Self-examination
  71. 1 in 8 women
  72. Breast Cancer
  73. Radiotherapy
  74. Ki-67 Rate
  75. Antibody Therapy
  76. Absolute Risk
  77. Genomic Testing
  78. Antiemetic
  79. Doxorubicin
  80. EGFR
  81. Chemoprevention
  82. Triple +/- Breast Cancer
  83. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  84. Paget Disease
  85. Down-Staging
  86. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  87. Lump
  88. Relapse
  89. Lymph Node Status
  90. Dimpling
  91. Intraductal Papilloma
  92. ER+
  93. PI3 Kinase Inhibitors
  94. Raloxifene
  95. Definitive Surgery
  96. Cytotoxic
  97. Flow Cytometry
  98. Estradiol
  99. Biopsy
  100. Fibroadenoma
  101. ECOG Score
  102. Oligometastases
  103. Angiogenesis
  104. Women ages 40+ should have a clinical breast exam at least yearly
  105. Bevacizumab
  106. Genetic Predisposition
  107. mTOR Inhibitors
  108. Phyllodes Tumor
  109. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  110. Hormone Receptor Status
  111. Apoptosis
  112. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  113. Tumor Grade
  114. Family History
  115. CDK4/6 Inhibitors
  116. BOCA
  117. SERM
  118. Lapatinib
  119. Docetaxel
  120. Breast Tomosynthesis